SCHEMBL5381228

SCHEMBL5381228

CCCCOc1cc(P(=O)(c2ccccc2)c2ccccc2)cc2c1OCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HIF1A Q16665 1/20 0.41
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
RAB9A P51151 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 2/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
KCNA3 P22001 1/20 0.37
MAOB P27338 2/20 0.36
GPR55 Q9Y2T6 1/20 0.36
MAOA P21397 1/20 0.36
HPGD P15428 1/20 0.36
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5395984 0.94 LMNA (0.40) ALDH1A1MAPTSMN1; SMN2RAB9AMEN1
SCHEMBL5378565 0.89 AOC3 (0.42) ALDH1A1MAPTSMN1; SMN2RAB9AMEN1
SCHEMBL5379331 0.82 ALDH1A1 (0.46) ALDH1A1MAPTSMN1; SMN2RAB9AKDM4E
SCHEMBL5391670 0.81 HIF1A (0.44) ALDH1A1HIF1AMAPTSMN1; SMN2RAB9A
SCHEMBL5376515 0.79 HIF1A (0.42) ALDH1A1HIF1AMAPTSMN1; SMN2RAB9A
SCHEMBL5378597 0.79 CASP3 (0.41) ALDH1A1MAPTSMN1; SMN2RAB9AKDM4E
SCHEMBL14337810 0.75 RAB9A (0.38) ALDH1A1MAPTSMN1; SMN2RAB9AKDM4E
SCHEMBL14337813 0.75 DHFR (0.42) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL14337812 0.75 ALKBH5 (0.40) ALDH1A1RAB9ACYP3A4NPC1TP53
SCHEMBL5383919 0.75 KMT2A (0.38) ALDH1A1HIF1AMAPTSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312347-B2 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-12-25 US disclosed
US-20070073065-A1 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070073065-A1 Substituted optically active disphosphine compound DHPS, DOHH, DHODH ALDH1A1 277/4885HIF1A 1529/4885MAPT 4288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.